This page contains information for ITN investigators about the ITN Publications Policy.
The most recent version of the Publications Policy may be downloaded below:
ITN Publications Policy
Revised: October 2022
Consort 2010 Statement
Updated guidelines for reporting parallel group randomized trials
Questions regarding ITN publication policy should be forwarded to:
Philip Bernstein, PhD
Director, Strategic Review, Planning & Communications
Phone: (240) 235-6132
Email: pbernstein@immunetolerance.org
